foxo4 dri senolytic FOXO4-DRI For Lab Research The FOXO4 peptide in a
The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o. foxo4 dri peptide senolytic 2024 Wolverine BPC 157 5mg, TB 500 5mg (10mg Blend) High Purity, U.S. Made Research Peptides FOX04 HLabs FOXO4 DRI: Kill Senescent Cells, Restore Organs (2026)
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




